Business
If FDA approval is materially delayed for any reason, it is possible that competitors will offer products with similar features before we are able to market the Acclaim CI.
Envoy Medical, Inc.: Revenue grew 7.1% to $241K from $225K. Net loss widened to $23.76M from $20.8M. Free cash flow outflow narrowed to $18.38M from $18.93M. Operating margin contracted 68244 bps to -9240.66%. Envoy Medical, Inc.'s annual comparison also shows stock compensation grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 7.1% to $241K from $225KOK
- Profitability — Net loss widened to $23.76M from $20.8MWatch
- Cash flow — Free cash flow outflow narrowed to $18.38M from $18.93MOK
- Margins — Operating margin contracted 68244 bps to -9240.66%Watch
- Accounting — Controls ineffective; going-concern warningWatch
- Insiders — 6 purchases and 0 salesOK
Where the revenue comes from
Fiscal 2025, as Envoy Medical, Inc. reports it. History and quarterly detail are in the app.
- All Other Segments$241K
Leadership changes
From Envoy Medical, Inc.'s own filings, the day they're filed.
- Robert Potashnick · Chief Accounting Officer · appointmenteff. 2026-08-24
- Robert Potashnick · Chief Financial Officer · appointmenteff. 2025-06-19
- Whitney Haring-Smith · directors · departureeff. 2024-06-07
Latest filings
- 8-K · Company announcement2026-08-27
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-06-30
- 8-K · Company announcement2026-06-25
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Envoy Medical, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.